ITI Using SCT800 Combining Daratumumab or SCT800 Alone in Hemophilia A Adolescents and Adults With High Titer Inhibitor
Condition: Hemophilia A With Inhibitor Intervention: Drug: SCT800 and Daratumumab Sponsors: Institute of Hematology & Blood Diseases Hospital; Sinocelltech Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials